Regenerative Medicine for Neurological Disorders
The annual meeting of the American Society for Neural Therapy and Repair (ASNTR) has always introduced us to top-notch and up-to-date approaches for regenerative medicine related to neuroscience, ranging from stem cell–based therapy to novel drugs. The 16th ASNTR meeting focused on a variety of diff...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1100/tsw.2010.39 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832558574351417344 |
|---|---|
| author | Dong-Hyuk Park David J. Eve Yong-Gu Chung Paul R. Sanberg |
| author_facet | Dong-Hyuk Park David J. Eve Yong-Gu Chung Paul R. Sanberg |
| author_sort | Dong-Hyuk Park |
| collection | DOAJ |
| description | The annual meeting of the American Society for Neural Therapy and Repair (ASNTR) has always introduced us to top-notch and up-to-date approaches for regenerative medicine related to neuroscience, ranging from stem cell–based therapy to novel drugs. The 16th ASNTR meeting focused on a variety of different topics, including the unknown pathogenesis or mechanisms of specific neurodegenerative diseases, stem cell biology, and development of novel alternative medicines or devices. Newly developed stem cells, such as amniotic epithelial stem cells and induced pluripotent stem cells, as well as well-known traditional stem cells, such as neural, embryonic, bone marrow mesenchymal, and human umbilical cord blood–derived stem cells, were reported. A number of commercialized stem cells were also covered at this meeting. Fetal neural tissues, such as ventral mesencephalon, striatum, and Schwann cells, were investigated for neurodegenerative diseases or spinal cord injury. A number of studies focused on novel methods for drug monitoring or graft tracking, and combination therapy with stem cells and medicine, such as cytokines or trophic factors. Finally, the National Institutes of Health guidelines for human stem cell research, clinical trials of commercialized stem cells without larger animal testing, and prohibition of medical tourism were big controversial issues that led to heated discussion. |
| format | Article |
| id | doaj-art-2ac81421d5184a33a4e4948b081c8a75 |
| institution | Kabale University |
| issn | 1537-744X |
| language | English |
| publishDate | 2010-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | The Scientific World Journal |
| spelling | doaj-art-2ac81421d5184a33a4e4948b081c8a752025-02-03T01:32:01ZengWileyThe Scientific World Journal1537-744X2010-01-011047048910.1100/tsw.2010.39Regenerative Medicine for Neurological DisordersDong-Hyuk Park0David J. Eve1Yong-Gu Chung2Paul R. Sanberg3Center of Excellence for Aging and Brain Repair, Department of Neurosurgery, University of South Florida College of Medicine, Tampa, FL, USACenter of Excellence for Aging and Brain Repair, Department of Neurosurgery, University of South Florida College of Medicine, Tampa, FL, USADepartment of Neurosurgery, Korea University Medical Center, Korea University College of Medicine, Seoul, South Korea, Republic of KoreaCenter of Excellence for Aging and Brain Repair, Department of Neurosurgery, University of South Florida College of Medicine, Tampa, FL, USAThe annual meeting of the American Society for Neural Therapy and Repair (ASNTR) has always introduced us to top-notch and up-to-date approaches for regenerative medicine related to neuroscience, ranging from stem cell–based therapy to novel drugs. The 16th ASNTR meeting focused on a variety of different topics, including the unknown pathogenesis or mechanisms of specific neurodegenerative diseases, stem cell biology, and development of novel alternative medicines or devices. Newly developed stem cells, such as amniotic epithelial stem cells and induced pluripotent stem cells, as well as well-known traditional stem cells, such as neural, embryonic, bone marrow mesenchymal, and human umbilical cord blood–derived stem cells, were reported. A number of commercialized stem cells were also covered at this meeting. Fetal neural tissues, such as ventral mesencephalon, striatum, and Schwann cells, were investigated for neurodegenerative diseases or spinal cord injury. A number of studies focused on novel methods for drug monitoring or graft tracking, and combination therapy with stem cells and medicine, such as cytokines or trophic factors. Finally, the National Institutes of Health guidelines for human stem cell research, clinical trials of commercialized stem cells without larger animal testing, and prohibition of medical tourism were big controversial issues that led to heated discussion.http://dx.doi.org/10.1100/tsw.2010.39 |
| spellingShingle | Dong-Hyuk Park David J. Eve Yong-Gu Chung Paul R. Sanberg Regenerative Medicine for Neurological Disorders The Scientific World Journal |
| title | Regenerative Medicine for Neurological Disorders |
| title_full | Regenerative Medicine for Neurological Disorders |
| title_fullStr | Regenerative Medicine for Neurological Disorders |
| title_full_unstemmed | Regenerative Medicine for Neurological Disorders |
| title_short | Regenerative Medicine for Neurological Disorders |
| title_sort | regenerative medicine for neurological disorders |
| url | http://dx.doi.org/10.1100/tsw.2010.39 |
| work_keys_str_mv | AT donghyukpark regenerativemedicineforneurologicaldisorders AT davidjeve regenerativemedicineforneurologicaldisorders AT yongguchung regenerativemedicineforneurologicaldisorders AT paulrsanberg regenerativemedicineforneurologicaldisorders |